Ritodrinium
Brand names,
Ritodrinium
Analogs
Ritodrinium
Brand Names Mixture
Ritodrinium
Chemical_Formula
C17H21NO3
Ritodrinium
RX_link
No information avaliable
Ritodrinium
fda sheet
Ritodrinium
msds (material safety sheet)
Ritodrinium
Synthesis Reference
Belg. pat. 660.244 (1965 to N.V. Philips), C.A. 63, 17965h (1965) corresp to Claassen et al., U.S. pat. 3,410,944 (1968 to No. Am. Philips)
Ritodrinium
Molecular Weight
287.354 g/mol
Ritodrinium
Melting Point
88-90 oC
Ritodrinium
H2O Solubility
Complete
Ritodrinium
State
Solid
Ritodrinium
LogP
2.588
Ritodrinium
Dosage Forms
Solution for IV; Capsule (extended-release); Tablet; Intramuscular injection
Ritodrinium
Indication
For the treatment and prophylaxis of premature labour
Ritodrinium
Pharmacology
Beta-2 adrenergic receptors are located at sympathetic neuroeffector junctions of many organs, including uterus. Ritodrine is beta-2 adrenergic agonist. It stimulates beta-2 adrenergic receptor, increases cAMP level and decreases intracellular calcium concentration. The decrease of calcium concentration leads to a relaxation of uterine smooth muscle.
Ritodrinium
Absorption
No information avaliable
Ritodrinium
side effects and Toxicity
LD50=64mg/kg (mice, IV); LD50=540 mg/kg (mice, oral); LD50=85 mg/kg (rat, IV)
Ritodrinium
Patient Information
Ritodrinium
Organisms Affected
Humans and other mammals